Log in

Involvement of TRPM4 in detrusor overactivity following spinal cord transection in mice

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Transient receptor potential cation channel subfamily M member 4 (TRPM4) has been shown to play a key role in detrusor contractility under physiological conditions. In this study, we investigated the potential role of TRPM4 in detrusor overactivity following spinal cord transection (SCT) in mice. TRPM4 expression and function were evaluated in bladder tissue with or without the mucosa from spinal intact (SI) and SCT female mice (T8-T9 vertebra; 1–28 days post SCT) using PCR, western blot, immunohistochemistry, and muscle strip contractility techniques. TRPM4 was expressed in the urothelium (UT) and detrusor smooth muscle (DSM) and was upregulated after SCT. Expression levels peaked 3–7 days post SCT in both the UT and DSM. Pharmacological block of TRPM4 with the antagonist, 9-Phenanthrol (30 μM) greatly reduced spontaneous phasic activity that developed after SCT, regardless of the presence or absence of the mucosa. Detrusor overactivity following spinal cord injury leads to incontinence and/or renal impairment and represents a major health problem for which current treatments are not satisfactory. Augmented TRPM4 expression in the bladder after chronic SCT supports the hypothesis that TRPM4 channels play a role in DSM overactivity following SCT. Inhibition of TRPM4 may be beneficial for improving detrusor overactivity in SCI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Download references

Acknowledgements

We thank Kyoung Kim, Morgan Benner, and Stephany Lynn Daugherty for technical support.

Funding

This work was supported by the following grants: R37 DK54824 to LAB, P01 DK093424 to WCD, LAB and AJK, P30 DK079307 O’Brien Pilot to FAK, R01 DK111382 to WCD, DK114492 and DK106115 to JMB.

Author information

Authors and Affiliations

Authors

Contributions

FAK designed and performed experiments, analyzed data, wrote manuscript. JMB, CG, BMcD, AWJ, and AML performed experiments, analyzed data, edited, and approved the manuscript. WCdeG contributed to drafting of the manuscript. IVZ, YI, and LAB edited and approved the manuscript.

Corresponding author

Correspondence to F. Aura Kullmann.

Ethics declarations

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the University of Pittsburgh animal care and use committee and followed the NIH Guidelines for the Care and Use of Laboratory Animals. This article does not contain any studies with human participants performed by any of the authors.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kullmann, F.A., Beckel, J.M., McDonnell, B. et al. Involvement of TRPM4 in detrusor overactivity following spinal cord transection in mice. Naunyn-Schmiedeberg's Arch Pharmacol 391, 1191–1202 (2018). https://doi.org/10.1007/s00210-018-1542-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-018-1542-0

Keywords

Navigation